Adopting MIGS devices
Research and practice are keys to successfully adding new devices and techniques
Howard Larkin
Published: Wednesday, March 1, 2017
Juan Battle MD
We have never lost an eye, we have always succeeded in Schlemmʼs canalFor example, in cannulating Schlemm’s canal, Dr Batlle has seen even glaucoma experts have problems. “Things all look the same - the pigment in front of Schwalbe’s looks like Schlemm’s, or it’s behind Schwalbe’s so you end up going higher, higher, higher because people want to put it way back in the trabecular meshwork. So have someone coach you,” he said. Fortunately, mistakes with MIGS devices usually are not serious, Dr Batlle added. “We have never lost an eye, we have always succeeded in Schlemmʼs canal. The worst that can happen is you don’t lower the intraocular pressure and you have to do it again.” Still, even a world-class surgeon like Dr Batlle needs practice. He recalls an Ivantis wetlab in Amsterdam introducing the Hydrus Microstent. “I was the only one there… I did 95 insertions of the Hydrus into cadaver eyes before I got it down.” Juan F Batlle: jbatlle55@gmail.com
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular
Long-awaited cellular therapies for corneal endothelial disease enter the clinic.
Balancing Innovation and Safety
Ensuring access to advanced cell therapies amid regulatory overhaul.
With Eyes on Its Future, ESCRS Celebrates Its Past
Winter Meeting offers opportunities to experiment with new concepts and formats.
Best of ESCRS Winter Meeting 2024
Following the New Generation
EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.
Refocus on Multifocals
Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.
Common Myths in Presbyopia Correction
Patient education key to satisfaction with refractive IOLs.
Reversible Multifocality
Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.
Managing a Cataract Surgery Refractive Miss
Weighing the pros and cons of options for intraocular intervention.
Unleashing OCT’s Full Potential
Performance of newest tool for corneal evaluation meets or beats older standard technologies.